Hurley Capital
AGIO icon

Hurley Capital’s Agios Pharmaceuticals AGIO Stock Holding History

Hurley Capital’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-120
Closed -$4.45K – 665
2026
Q2 		$4.45K Hold
120
– – ﹤0.01% 463
2026
Q1 		$4.06K Sell
120
-366
-75% -$10.4K ﹤0.01% 480
2025
Q4 		$13.2K Buy
486
+120
+33% +$4.21K 0.01% 301
2025
Q3 		$14.7K Hold
366
– – 0.01% 317
2025
Q2 		$12.2K Hold
366
– – 0.01% 289
2025
Q1 		$10.7K Buy
+366
New +$12.1K 0.01% 315

Other funds holding AGIO

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Hurley Capital's AGIO Position: Q3 2026 in Review

Hurley Capital sold out of Agios Pharmaceuticals (AGIO) in Q3 2026, closing a stake of 120 shares — an estimated $4.45K sold.

Hurley Capital first reported a position in AGIO in Q1 2025 and held it in 6 quarters. The position peaked at $14.7K in Q3 2025. 85 funds tracked by Wall St. Rank hold AGIO as of Q3 2026.

  • Hurley Capital reported no remaining Agios Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Hurley Capital sold 120 Agios Pharmaceuticals shares in Q3 2026, an estimated $4.45K.
  • Hurley Capital first reported a position in Agios Pharmaceuticals in Q1 2025 and held it in 6 quarters.
  • Hurley Capital's Agios Pharmaceuticals position peaked at $14.7K in Q3 2025.
  • 85 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2026.

Based on Hurley Capital's 13F filing for Q3 2026, filed 5 Nov 2026.